Long Read Sequencing Market Size Is Predicted To Reach A Valuation Of $3.4 Billion By 2025

The global long read sequencing market size is expected to reach USD 3.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 23.5% CAGR over the forecast period. Rapid advancements in third-generation long-read sequence analysis techniques are expected to bring a new era of research in the field of medical and biological sciences.

In addition, advantages offered by single-molecule real-time sequencing (SMRT) and Nanopore platforms over second-generation technologies are anticipated to enhance the adoption of these protocols. For instance, long reads generated by SMRT sequencers span across possible repetitive regions and provide a comprehensive view of the whole genome. Therefore, these technologies are adopted in the identification of genetic and structural variants.

Owing to the advantages offered by long-read technology, manufacturers are increasingly enhancing their product offerings to overcome technical as well as data analysis limitations. For instance, in January 2019, Oxford Nanopore Technologies launched NanoPipe, a web server for data analysis of nanopore MinION. The software is designed such that it can be easily used by wet-lab biologists with little knowledge about bioinformatics platforms as well as experienced bioinformaticians.

Browse full research report on Long Read Sequencing Market: https://www.grandviewresearch.com/industry-analysis/long-read-sequencing-market

Further key findings from the report suggest:

• The SMRT segment accounted for a major share by technology in 2018 and is projected to maintain its dominance throughout the forecast period. Factors such as longer reads, high accuracy, and modified base detection make SMRT a method of choice for complete genome analysis
• Nanopore technology is anticipated to witness lucrative growth owing to the portable nature of commercially available Nanopore sequencers. This property of Nanopore sequencers makes them useful in generation of immediate, real-time data during viral outbreaks in remote areas
• On the basis of product, consumables formed the largest revenue generating segment in 2018 and is estimated to remain so throughout the forecast period owing to high utilization of consumables in every step across the workflow
• By application, identification & fine mapping of structural variation occupied a major share in 2018 as long reads allow efficient distinction of haplotypes and enhance the accuracy of analysis of structural variations
• Based on workflow, the data analysis segment is expected to expand at a lucrative CAGR owing to efforts taken by several product manufacturers to enhance adoption of data analysis software
• Academic research accounted for the largest share by end use as a result of higher usage of these methodologies in research, academic workshops, and on-site bioinformatics courses offered by universities
• Asia Pacific is expected to expand at the fastest growth rate throughout the forecast period. Lucrative opportunities offered by emerging nations has attracted investments from global firms in the region
• Pacific Biosciences of California, Inc. and Oxford Nanopore Technologies Limited are some of the prominent participants operating in this market. These participants are engaged in new product development and strategic alliances to maintain market share.

Browse request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/long-read-sequencing-market/request/rs1

Grand View Research has segmented the global long read sequencing market on the basis of technology, product, application, work flow, end use, and region:

Long Read Sequencing Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Single-Molecule Real-Time Sequencing (SMRT)
• Nanopore Sequencing

Long Read Sequencing Product Outlook (Revenue, USD Million, 2014 - 2025)

• Instruments
• Consumables
• Services

Long Read Sequencing Application Outlook (Revenue, USD Million, 2014 - 2025)

• Identification & Fine Mapping of Structural Variation
• Tandem Repeat Sequencing
• Pseudogene Discrimination 
• Resolving Allele Phasing
• Reproductive Genomics 
• Cancer 
• Viral & Microbial Sequencing
• Others

Long Read Sequencing Workflow Outlook (Revenue, USD Million, 2014 - 2025)

• Pre-Sequencing
• Sequencing
• Data Analysis

Long Read Sequencing End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other

Long Read Sequencing Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• MEA
• South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com